We are live on
!
Find out more
BNP Paribas Asset Management Portfolio holdings
AUM
$86.1B
1-Year Est. Return
29.11%
This Fund
S&P 500
This Quarter
Est. Return
-2.17%
1 Year Est. Return
+29.11%
3 Year Est. Return
+87.64%
5 Year Est. Return
+102.48%
10 Year Est. Return
+408.22%
AUM
$86.1B
AUM Growth
-$1.05B
(-1.2%)
Cap. Flow
+$4.86B
Cap. Flow
% of AUM
5.64%
Top 10 Holdings %
Top 10 Hldgs %
27.63%
Holding
2,366
New
101
Increased
1,396
Reduced
686
Closed
108
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$1.43B |
| 2 |
TotalEnergies
TTE
|
+$626M |
| 3 |
Deutsche Bank
DB
|
+$326M |
| 4 |
Stellantis
STLA
|
+$263M |
| 5 |
Broadcom
AVGO
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ciena
CIEN
|
+$291M |
| 2 |
Apple
AAPL
|
+$262M |
| 3 |
Amazon
AMZN
|
+$219M |
| 4 |
Tesla
TSLA
|
+$205M |
| 5 |
Meta Platforms (Facebook)
META
|
+$197M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.22% |
| 2 | Healthcare | 13.97% |
| 3 | Financials | 10.51% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 8.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Klaviyo
KVYO
$5.78B
| $3.07M | ﹤0.01% |
157,842
-455,192
| -74% | -$9.76M |
|
927
Diebold Nixdorf
DBD
$2.65B
| $3.07M | ﹤0.01% |
40,687
+108
| +0.3% | +$7.95K |
|
928
Broadstone Net Lease
BNL
$4.07B
| $3.04M | ﹤0.01% |
166,535
-19,819
| -11% | -$373K |
|
929
ASE Group
ASX
$80.9B
| $3.02M | ﹤0.01% |
139,381
+880
| +0.6% | +$18.5K |
|
930
Outfront Media
OUT
$5.64B
| $2.99M | ﹤0.01% |
112,936
+725
| +0.6% | +$18.9K |
|
931
Dyne Therapeutics
DYN
$4.89B
| $2.99M | ﹤0.01% |
164,887
-805
| -0.5% | -$13.9K |
|
932
Deluxe
DLX
$1.22B
| $2.98M | ﹤0.01% |
108,354
-12,722
| -11% | -$333K |
|
933
SoFi Technologies
SOFI
$23.5B
| $2.98M | ﹤0.01% |
187,642
-46,067
| -20% | -$971K |
|
934
American Eagle Outfitters
AEO
$2.99B
| $2.97M | ﹤0.01% |
177,926
-5,124
| -3% | -$115K |
|
|
ECG
935
Everus Construction Group
ECG
$7.18B
| $2.96M | ﹤0.01% |
25,052
-2,347
| -9% | -$243K |
|
936
Sabra Healthcare REIT
SBRA
$5.32B
| $2.88M | ﹤0.01% |
149,850
+129,211
| +626% | +$2.55M |
|
937
Immunocore
IMCR
$1.69B
| $2.86M | ﹤0.01% |
94,936
-968
| -1% | -$31.3K |
|
938
Herbalife
HLF
$1.31B
| $2.85M | ﹤0.01% |
193,673
-9,643
| -5% | -$158K |
|
939
LiveRamp
RAMP
$2.3B
| $2.84M | ﹤0.01% |
106,981
+106,118
| +12,296% | +$2.78M |
|
940
Certara
CERT
$1.25B
| $2.81M | ﹤0.01% |
+492,750
| New | +$3.76M |
|
941
American Healthcare REIT
AHR
$10.7B
| $2.79M | ﹤0.01% |
59,217
+318
| +0.5% | +$15.8K |
|
942
Crescent Energy
CRGY
$3.63B
| $2.77M | ﹤0.01% |
205,126
-177,233
| -46% | -$1.86M |
|
943
Yelp
YELP
$1.41B
| $2.76M | ﹤0.01% |
111,737
+1,101
| +1% | +$27.9K |
|
|
CALY
944
Callaway Golf Company
CALY
$3.44B
| $2.76M | ﹤0.01% |
199,078
+196,856
| +8,859% | +$2.76M |
|
945
New Oriental
EDU
$9.06B
| $2.76M | ﹤0.01% |
+48,747
| New | +$2.78M |
|
946
Viridian Therapeutics
VRDN
$2.33B
| $2.74M | ﹤0.01% |
140,260
+139,364
| +15,554% | +$4.14M |
|
947
Factset
FDS
$9.89B
| $2.74M | ﹤0.01% |
12,643
+6,392
| +102% | +$1.49M |
|
948
Astronics
ATRO
$3.81B
| $2.73M | ﹤0.01% |
49,153
+48,702
| +10,799% | +$2.94M |
|
949
Live Nation Entertainment
LYV
$42.8B
| $2.71M | ﹤0.01% |
17,750
-3,412
| -16% | -$517K |
|
950
Enact Holdings
ACT
$6.68B
| $2.71M | ﹤0.01% |
66,321
-7,527
| -10% | -$308K |
|
Similar funds
BNP Paribas Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, BNP Paribas Asset Management held 2,366 positions worth $86.1B, down 1.2% from $87.2B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
BNP Paribas Asset Management deployed $4.86B of net new capital in Q1 2026, opening 101 new positions and adding to 1,396 existing holdings. Its largest new stake was Viking Holdings: 1,864,036 shares worth $137M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Ciena, an estimated $291M trimmed.
- BNP Paribas Asset Management's largest Q1 2026 buy was Viking Holdings: 1,864,036 shares worth $137M.
- BNP Paribas Asset Management added most to AstraZeneca in Q1 2026, an estimated $1.43B increase.
- BNP Paribas Asset Management's biggest Q1 2026 reduction was Ciena, cutting an estimated $291M.
- BNP Paribas Asset Management fully exited Exact Sciences in Q1 2026, selling an estimated $35.9M.
- BNP Paribas Asset Management's ten largest holdings make up 28% of its $86.1B portfolio in Q1 2026.
- BNP Paribas Asset Management opened 101 new positions and closed 108 in Q1 2026.
- BNP Paribas Asset Management's portfolio value fell 1.2% quarter-over-quarter to $86.1B.
Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.